 categories of
rest pain, ischemic ulceration, and gangrene (Rutherford
4, 5, and 68; Fontaine III, IV14), while adequate for identifying patients at increased risk for major limb amputation
and death, are not sufÔ¨Åciently detailed to stratify the range
of risk or determine best therapy across this heterogeneous
spectrum of patients. Controversies over revascularization
approaches (open bypass vs endovascular therapy),